Logos Global Management »

Pepgen shares owned by Logos Global Management

Quarter-by-quarter ownership of Pepgen (PEPG) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Pepgen

Tip: Access up to 7 years of quarterly data

All positions including Pepgen held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pepgen by Logos Global Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.5M 750k 4.62

More positions owned by Logos Global Management

Revolution Medicines Call Option (RVMD)
Ideaya Biosciences Call Option (IDYA)
Akero Therapeutics (AKRO)
Arvinas Ord (ARVN)
Ocular Therapeutix (OCUL)
Cidara Therapeutics Com New (CDTX)
Verastem Com New (VSTM)
Abivax Sa Sponsored Ads (ABVX)
Janux Therapeutics (JANX)
Erasca (ERAS)
Maze Therapeatics (MAZE)
Olema Pharmaceuticals (OLMA)
Immunocore Hldgs Ads (IMCR)
Dyne Therapeutics (DYN)
Disc Medicine (IRON)

View all positions for Logos Global Management

Top funds holding Pepgen

RA Capital Management
Viking Global Investors
Commodore Capital
Vivo Capital
Point72 Asset Management
BVF
Laurion Capital Management
Vanguard Group
Henderson Group
Rtw Investments
Adage Capital Partners GP
Balyasny Asset Management
Woodline Partners
Deep Track Capital
TCG Crossover Management

View all funds holding Pepgen